CH583196A5 - - Google Patents

Info

Publication number
CH583196A5
CH583196A5 CH1160673A CH1160673A CH583196A5 CH 583196 A5 CH583196 A5 CH 583196A5 CH 1160673 A CH1160673 A CH 1160673A CH 1160673 A CH1160673 A CH 1160673A CH 583196 A5 CH583196 A5 CH 583196A5
Authority
CH
Switzerland
Application number
CH1160673A
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CH583196A5 publication Critical patent/CH583196A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1160673A 1972-08-12 1973-08-10 CH583196A5 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2239815A DE2239815C2 (de) 1972-08-12 1972-08-12 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH583196A5 true CH583196A5 (pl) 1976-12-31

Family

ID=5853453

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1160673A CH583196A5 (pl) 1972-08-12 1973-08-10

Country Status (29)

Country Link
US (1) US3959292A (pl)
JP (1) JPS5626660B2 (pl)
KR (1) KR780000072B1 (pl)
AT (1) AT327194B (pl)
AU (1) AU469267B2 (pl)
BE (1) BE803474A (pl)
BG (1) BG22816A3 (pl)
CA (1) CA1016945A (pl)
CH (1) CH583196A5 (pl)
CS (1) CS178892B2 (pl)
DD (1) DD109627A5 (pl)
DE (1) DE2239815C2 (pl)
DK (1) DK136062C (pl)
ES (1) ES417807A1 (pl)
FI (1) FI55998C (pl)
FR (1) FR2195450B1 (pl)
GB (1) GB1384219A (pl)
HU (1) HU167991B (pl)
IE (1) IE37989B1 (pl)
IL (1) IL42933A (pl)
LU (1) LU68206A1 (pl)
NL (1) NL7311031A (pl)
NO (1) NO139130C (pl)
PL (1) PL89396B1 (pl)
RO (1) RO62914A (pl)
SE (1) SE386164B (pl)
SU (1) SU475772A3 (pl)
YU (1) YU36172B (pl)
ZA (1) ZA735460B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639257A1 (de) * 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4442100A (en) * 1979-12-11 1984-04-10 Bayer Aktiengesellschaft Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
EP0094159B1 (en) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives, their production and use
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
CA1267416A (en) 1985-06-17 1990-04-03 Ila Sircar 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
SE8701172D0 (sv) * 1987-03-20 1987-03-20 Sandvik Ab Whiskerforsterkt keramiskt skerverktyg
EP3730264B1 (en) 2017-12-22 2022-08-24 Toray Industries, Inc. Tape-shaped prepreg and production method therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester

Also Published As

Publication number Publication date
YU36172B (en) 1982-02-25
JPS4945079A (pl) 1974-04-27
JPS5626660B2 (pl) 1981-06-19
SE386164B (sv) 1976-08-02
AU5912473A (en) 1975-02-13
IE37989L (en) 1974-02-12
BG22816A3 (bg) 1977-04-20
ES417807A1 (es) 1976-03-01
DD109627A5 (pl) 1974-11-12
YU213373A (en) 1981-06-30
AU469267B2 (en) 1976-02-05
PL89396B1 (pl) 1976-11-30
SU475772A3 (ru) 1975-06-30
NO139130B (no) 1978-10-02
IL42933A (en) 1977-04-29
CS178892B2 (en) 1977-10-31
DK136062B (da) 1977-08-08
AT327194B (de) 1976-01-26
DE2239815A1 (de) 1974-02-21
LU68206A1 (pl) 1973-10-16
ZA735460B (en) 1974-07-31
KR780000072B1 (en) 1978-03-30
RO62914A (fr) 1977-11-15
IL42933A0 (en) 1973-11-28
FI55998B (fi) 1979-07-31
FR2195450A1 (pl) 1974-03-08
DE2239815C2 (de) 1983-02-10
HU167991B (pl) 1976-02-28
NO139130C (no) 1979-01-10
DK136062C (da) 1978-01-09
ATA707073A (de) 1975-04-15
GB1384219A (en) 1975-02-19
NL7311031A (pl) 1974-02-14
CA1016945A (en) 1977-09-06
BE803474A (fr) 1974-02-11
FR2195450B1 (pl) 1977-09-09
US3959292A (en) 1976-05-25
IE37989B1 (en) 1977-11-23
FI55998C (fi) 1979-11-12

Similar Documents

Publication Publication Date Title
FR2195450B1 (pl)
JPS48100501U (pl)
JPS48105042U (pl)
JPS4991403A (pl)
FR2192706A5 (pl)
JPS49104203U (pl)
JPS4983907U (pl)
JPS499432U (pl)
JPS4926795U (pl)
CH566566A5 (pl)
CH590850A5 (pl)
CH565885A5 (pl)
CH565301A5 (pl)
CH580150A5 (pl)
NL7309586A (pl)
CH566631A5 (pl)
BG17145A1 (pl)
AU936672A (pl)
CH565246A5 (pl)
CH567700A5 (pl)
CH569571A5 (pl)
CH563676A5 (pl)
CH587276A5 (pl)
CH563553A5 (pl)
CH566060A5 (pl)

Legal Events

Date Code Title Description
PL Patent ceased